Next Quarterly Earnings
No earnings planned
Currently, no future quarterly earnings are announced for this company.BioVersys AG is a Swiss biopharmaceutical company based in Basel. It develops novel antibiotics and compounds targeting antimicrobial resistance, addressing hard-to-treat bacterial infections such as tuberculosis and hospital-acquired infections.
BioVersys last reported quarterly earnings on 9/9/2026 (Q2 2026). Earnings per share (EPS) came in at -2.66 CHF.
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.